Direkt zum Inhalt
Merck
  • Exploring advantages/disadvantages and improvements in overcoming gene delivery barriers of amino acid modified trimethylated chitosan.

Exploring advantages/disadvantages and improvements in overcoming gene delivery barriers of amino acid modified trimethylated chitosan.

Pharmaceutical research (2014-12-24)
Hao Zheng, Cui Tang, Chunhua Yin
ZUSAMMENFASSUNG

Present study aimed at exploring advantages/disadvantages of amino acid modified trimethylated chitosan in conquering multiple gene delivery obstacles and thus providing comprehensive understandings for improved transfection efficiency. Arginine, cysteine, and histidine modified trimethyl chitosan were synthesized and employed to self-assemble with plasmid DNA (pDNA) to form nanocomplexes, namely TRNC, TCNC, and THNC, respectively. They were assessed by structural stability, cellular uptake, endosomal escape, release behavior, nuclear localization, and in vitro and in vivo transfection efficiencies. Besides, sodium tripolyphosphate (TPP) was added into TRNC to compromise certain disadvantageous attributes for pDNA delivery. Optimal endosomal escape ability failed to bring in satisfactory transfection efficiency of THNC due to drawbacks in structural stability, cellular uptake, pDNA liberation, and nuclear distribution. TCNC evoked the most potent gene expression owing to multiple advantages including sufficient stability, preferable uptake, efficient pDNA release, and high nucleic accumulation. Undesirable stability and insufficient pDNA release adversely affected TRNC-mediated gene transfer. However, incorporation of TPP could improve such disadvantages and consequently resulted in enhanced transfection efficiencies. Coordination of multiple contributing effects to conquer all delivery obstacles was necessitated for improved transfection efficiency, which would provide insights into rational design of gene delivery vehicles.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Deuteriumoxid, 99.9 atom % D
Sigma-Aldrich
N-Hydroxysuccinimid, 98%
Sigma-Aldrich
L-Glutathion reduziert, suitable for cell culture, BioReagent, ≥98.0%, powder
Sigma-Aldrich
Deuteriumoxid, 99.9 atom % D, contains 0.05 wt. % 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt
Sigma-Aldrich
L-Arginin -monohydrochlorid, not synthetic, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
Nocodazol, ≥99% (TLC), powder
Sigma-Aldrich
Fluoreszein-5(6)-isothiocyanat, BioReagent, suitable for fluorescence, mixture of 2 components, ≥90% (HPLC)
Sigma-Aldrich
L-Arginin -monohydrochlorid, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
Deuteriumoxid, 99.9 atom % D, contains 0.75 wt. % 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid, sodium salt
SAFC
L-Arginin -monohydrochlorid
Sigma-Aldrich
Deuteriumoxid, filtered, 99.8 atom % D
Sigma-Aldrich
Deuteriumoxid, 99.9 atom % D, contains 1 % (w/w) 3-(trimethylsilyl)-1-propanesulfonic acid, sodium salt (DSS)
Sigma-Aldrich
L-Glutathion reduziert, ≥98.0%
Sigma-Aldrich
Fluoreszein-5(6)-isothiocyanat, ≥90% (HPLC)
Sigma-Aldrich
Fluorescein-Isothiocyanat Isomer I, ≥97.5% (HPLC)
Sigma-Aldrich
1,2-Dichlorethan, anhydrous, 99.8%
Sigma-Aldrich
DL-Cystein, technical grade
Sigma-Aldrich
Boc-His-OH, 99%
Sigma-Aldrich
L-Arginin -monohydrochlorid, reagent grade, ≥98% (HPLC), powder
Sigma-Aldrich
Deuteriumoxid, 70 atom % D
Sigma-Aldrich
L-Glutathion reduziert, BioXtra, ≥98.0%
Sigma-Aldrich
Deuteriumoxid, 60 atom % D